Moderna Inc annual operating income for fiscal TTM was -$3.4 billion, a decrease of 11.0% from -$3.1 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Operating Income (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income (EBIT) | ($3.4B) | ($3.1B) | ($3.9B) | ($4.2B) | $9.4B | $13.3B | ($763M) | ($546M) | ($413M) | ($269M) | ($224M) | ($1M) | ($4M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Operating Income (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Operating Income (EBIT) | ($1.4B) | ($857M) | ($260M) | ($907M) | ($1.1B) | ($1.2B) | ($70M) | ($1.4B) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More MRNA metrics: Revenue · Gross Profit · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All MRNA financial statements → Interactive MRNA charts →
About TickerBase · Data methodology & sources